Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Factors Influencing the Pharmacokinetics (PK of the Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN-38G published Wed, Nov 7, 2007 - 10:31 EST

Factors Influencing the Pharmacokinetics (PK of the Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN-38G

Presented at the 2002 ACCP Annual Meeting, Albuquerque, NM

Download this PDF file. (Instructions for downloading)
Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Factors Influencing the Pharmacokinetics (PK of the Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN-38G published Wed, Nov 7, 2007 - 10:31 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top